Metraipolis › archive › dc_d89ccdb5ce35

Current and future immunotherapies for NSCLC — Europe PMC PMID:42057114

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42057114
DOI: 10.1186/s13045-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-11-03T02:10:17.351Z
SHA-256 of the archived text: 002239b3b2351ee5b3baf641f1aa50f5e47da3f0c169dad8448c06d1093d50ff
Stable URL of this page: https://metraipolis.com/documento/dc_d89ccdb5ce35

How to cite

Current and future immunotherapies for NSCLC — Europe PMC PMID:42057114 — Europe PMC (en), https://europepmc.org/article/MED/42057114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d89ccdb5ce35 (Metraipolis archive dc_d89ccdb5ce35, sha256 002239b3b2351ee5b3baf641f1aa50f5e47da3f0c169dad8448c06d1093d50ff)

BibTeX

@misc{dcd89ccdb5ce35,
  title = {Current and future immunotherapies for NSCLC — Europe PMC PMID:42057114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42057114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d89ccdb5ce35; sha256 002239b3b2351ee5b3baf641f1aa50f5e47da3f0c169dad8448c06d1093d50ff},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42057114. Agents can read the archived copy with the MCP tool read_document.